EGX-A

In this article, we are going to address the topic of EGX-A from an innovative and relevant perspective for our readers. Whether EGX-A is a person, a topic, a date or another element, it is crucial to understand its impact on the world today and how it is influencing different aspects of society. Through an in-depth and detailed analysis, we will explore the many facets of EGX-A and its implications in various areas. Our goal is to provide our readers with a complete and up-to-date understanding of EGX-A, so that they can stay abreast of the latest developments and trends related to this topic.

EGX-A
Clinical data
Other namesEGXA
Drug classSerotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen

EGX-A is a serotonin 5-HT2A receptor agonist and putative serotonergic psychedelic which is under development for the treatment of depressive disorders.[1][2][3] It acts as a full agonist of the serotonin 5-HT2A receptor, shows high selectivity (>100-fold) for the serotonin 5-HT2A receptor over the serotonin 5-HT2B receptor, is much more potent as a serotonin 5-HT2A receptor agonist than psilocin, produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents, and produces antidepressant-like effects in rodents.[3] The drug is being developed by atai Life Sciences and EntheogeniX Biosciences.[1][2] As of January 2024, it is in the preclinical research stage of development.[1][2]

See also

References

  1. ^ a b c "EGX A - AdisInsight". adisinsight.springer.com.
  2. ^ a b c "Delving into the Latest Updates on EGX-A with Synapse". Synapse. 25 January 2025. Retrieved 16 February 2025.
  3. ^ a b Bowen C, Khan T, Perni R, Aron R, Gibbs A, Shin R, et al. (December 2023). "ACNP 62nd Annual Meeting: Poster Abstracts P251 – P500: P362. Discovery of Novel 5-HT2A Receptor Agonists With Psychedelic Drug-Like in Vitro and in Vivo Pharmacological Activity and Therapeutic Potential for Treatment-Resistant Depression". Neuropsychopharmacology. 48 (Suppl 1): 211–354 (275–275). doi:10.1038/s41386-023-01756-4. PMC 10729596. PMID 38040810.



Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.